We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWO
3251
CALL
Two Harbors Investment
TWO
$1.27B
$6.45M ﹤0.01%
324,000
+11,125
+4% +$225K
CYRX icon
3252
PUT
CryoPort
CYRX
$772M
$6.45M ﹤0.01%
208,100
+102,800
+98% +$2.73M
GFS icon
3253
PUT
GlobalFoundries
GFS
$30B
$6.45M ﹤0.01%
159,800
-578,400
-78% -$30.6M
HRL icon
3254
PUT
Hormel Foods
HRL
$13.5B
$6.45M ﹤0.01%
136,100
+81,300
+148% +$4.06M
ACAD icon
3255
CALL
Acadia Pharmaceuticals
ACAD
$4.87B
$6.44M ﹤0.01%
457,200
+325,900
+248% +$6.08M
CRL icon
3256
CALL
Charles River Laboratories
CRL
$13.4B
$6.44M ﹤0.01%
30,100
-3,400
-10% -$831K
MFA
3257
MFA Financial
MFA
$926M
$6.44M ﹤0.01%
598,857
+154,767
+35% +$2.08M
NTCT icon
3258
NETSCOUT
NTCT
$2.88B
$6.43M ﹤0.01%
189,984
-2,008
-1% -$67.4K
GCO icon
3259
Genesco
GCO
$391M
$6.43M ﹤0.01%
+128,817
New +$7.72M
AVAV icon
3260
CALL
AeroVironment
AVAV
$9.76B
$6.43M ﹤0.01%
78,200
+27,300
+54% +$2.43M
PRI icon
3261
Primerica
PRI
$9.65B
$6.43M ﹤0.01%
53,701
+8,384
+19% +$1.05M
CGNX icon
3262
Cognex
CGNX
$11B
$6.42M ﹤0.01%
+151,017
New +$8.46M
SFR
3263
DELISTED
Appreciate Holdings, Inc. Class A Common Stock
SFR
$6.42M ﹤0.01%
650,195
-500,097
-43% -$4.92M
XP icon
3264
XP
XP
$8.17B
$6.42M ﹤0.01%
357,283
+123,352
+53% +$2.84M
MOH icon
3265
PUT
Molina Healthcare
MOH
$11.1B
$6.4M ﹤0.01%
22,900
-9,800
-30% -$2.96M
BLTS
3266
DELISTED
Bright Lights Acquisition Corp. Class A Common Stock
BLTS
$6.4M ﹤0.01%
650,601
-565
-0.1% -$5.57K
KOLD icon
3267
CALL
ProShares UltraShort Bloomberg Natural Gas
KOLD
$105M
$6.4M ﹤0.01%
319,720
+274,170
+602% +$4.36M
ITQ
3268
DELISTED
Itiquira Acquisition Corp. Class A Ordinary Shares
ITQ
$6.4M ﹤0.01%
650,175
+131
+0% +$1.29K
HAS icon
3269
Hasbro
HAS
$13.6B
$6.39M ﹤0.01%
78,079
-229,640
-75% -$19.9M
ACH
3270
Accendra Health
ACH
$73.1M
$6.39M ﹤0.01%
203,052
+162,435
+400% +$5.88M
SUM
3271
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$6.38M ﹤0.01%
278,766
-288,499
-51% -$7.66M
EWW icon
3272
PUT
iShares MSCI Mexico ETF
EWW
$1.86B
$6.38M ﹤0.01%
137,000
+41,300
+43% +$2.07M
LHC
3273
DELISTED
Leo Holdings Corp. II
LHC
$6.37M ﹤0.01%
646,291
-998,145
-61% -$9.81M
OTIS icon
3274
CALL
Otis Worldwide
OTIS
$27.6B
$6.37M ﹤0.01%
90,100
+45,000
+100% +$3.31M
OPTU
3275
PUT
Optimum Communications Inc
OPTU
$251M
$6.35M ﹤0.01%
686,700
+466,900
+212% +$4.89M

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.